Teva To Sue FDA Over Pravachol Marketing Exclusivity
Law360 (July 6, 2005, 12:00 AM EDT) -- Israeli drug maker Teva Pharmaceutical Industries Ltd. said Wednesday it would sue the U.S. Food and Drug Administration over a decision that effectively wiped out the company’s marketing exclusivity for a...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
